TRACY ESTES: Open Payments
NPI 1194919506 · WILMINGTON, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$13,846 in 147 payments from 20 companies in 2025. Trend: 2023 $19,296 · 2024 $15,051 · 2025 $13,846
Consulting: $7,152Food & beverage: $3,320Travel & lodging: $3,273Education: $100
| Company | Payments | Amount |
|---|---|---|
| Pharming Healthcare, Inc. | 50 | $11,408 |
| GENZYME CORPORATION | 9 | $387 |
| AstraZeneca Pharmaceuticals LP | 17 | $363 |
| GlaxoSmithKline, LLC. | 11 | $290 |
| CSL Behring | 9 | $231 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $223 |
| Novartis Pharmaceuticals Corporation | 11 | $196 |
| Ionis Pharmaceuticals, Inc. | 7 | $163 |
| LEO Pharma Inc. | 3 | $155 |
| ARS Pharmaceuticals Operations, Inc. | 6 | $107 |
Products named: RUCONEST, DUPIXENT, NUCALA, TEZSPIRE, ANZUPGO, TAKHZYRO, Hizentra, NEFFY.
Industry payments across DE — which companies pay providers there.
